In this systematic review, ALPK1 was discovered to upregulate myosin IIA in monosodium-urate-treated cells [34], whereas ALPK1 was found to downregulate myosin IIA in oral cancer cells [29]. This evidence concerns the gene ALPK1 and lip and oral cavity carcinoma.